Fundraising Fox

Locus Biosciences

Raleigh, US · Founded 2015 · Delaware corporation · 6 known investors

locus-bio.com ↗
Biotechin /locus-biosciences-inc.@locusbio

Founders & leadership

GG
GEOFFREY GLASSDirector
DJ
DAVID JOHNSTONDirector
NT
NICK TAYLORExecutive Officer
PG
PAUL GAROFOLOExecutive Officer, Director
BB
BARY BAILEYDirector
CB
CHUCK BRAMLAGEDirector

Investors · 6

Abstract VenturesSan Francisco
Artis VenturesSan Francisco · $50K – $25M
Hemisphere Ventures LLC
AbstractreportedSan Francisco · $250K – $750K
Abstract VenturesreportedSan Francisco · $100K – $1M
Starlight VenturesreportedMiami · $100K – $3M

Reported raises · per SEC filings

Form D private placements
▶$10.6MraisedFeb 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bary BaileyDirector
  • David OusteroutExecutive Officer
  • Joseph NixonExecutive Officer
  • Stuart PetersonDirector
  • Paul GarofoloExecutive Officer, Director
Offering amount
$20M
Amount sold
$10.6M
First sale
Jan 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedNov 2020 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • STUART PETERSONDirector
  • BARY BAILEYDirector
  • PAUL GAROFOLOExecutive Officer, Director
Offering amount
$20M
Amount sold
$20M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedJul 2018 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • STUART PETERSONDirector
  • BARY BAILEYDirector
  • PAUL GAROFOLOExecutive Officer, Director
Offering amount
$7M
Amount sold
$7M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedOct 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • PAUL GAROFOLOExecutive Officer, Director
  • BARY BAILEYDirector
  • STUART PETERSONDirector
Offering amount
$14M
Amount sold
$7M
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$350KraisedDec 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • BARY BAILEYDirector
  • GEOFFREY GLASSDirector
  • NICK TAYLORExecutive Officer
  • CHUCK BRAMLAGEDirector
  • PAUL GAROFOLOExecutive Officer, Director
  • DAVID JOHNSTONDirector
Offering amount
$7M
Amount sold
$350K
First sale
Dec 2016
Incorporated
Corporation, North Carolina, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedApr 2016 · 62 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • GEOFFREY GLASSDirector
  • DAVID JOHNSTONDirector
  • NICK TAYLORExecutive Officer
  • PAUL GAROFOLOExecutive Officer, Director
  • BARY BAILEYDirector
  • CHUCK BRAMLAGEDirector
Offering amount
$1.5M
Amount sold
$1.3M
First sale
Jan 2016
Incorporated
Corporation, North Carolina, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.